Eugene Zhukovsky

Nessuna posizione attualmente

65 anni

Health Technology

Consumer Services

Profilo

Dr. Eugene Zhukovsky is Chief Scientific Officer & Member-Management Board at Affimed Therapeutics AG and Chief Scientific Officer at Affimed NV.
Dr. Zhukovsky was previously employed as a Principal by Xencor, Inc. He received his graduate degree from the St. Petersburg University of Economics & Finance and a doctorate degree from Brandeis University.

Precedenti posizioni note di Eugene Zhukovsky

Società	Posizione	Fine
AFFIMED N.V.	Direttore Tecnico/Scientifico/R&S	31/03/2014
XENCOR, INC.	Corporate Officer/Principal	01/01/2009
Affimed NV Niederlassung Deutschland Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Eugene Zhukovsky

Formazione di Eugene Zhukovsky

Brandeis University	Doctorate Degree
Saint Petersburg State University of Economics	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eugene Zhukovsky

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
XENCOR, INC.	Health Technology
AFFIMED N.V.	Health Technology

Aziende private	1
Affimed NV Niederlassung Deutschland Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.	Health Technology